Double Medical Technology Inc. (SHE:002901)

Double Medical Technology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Market Capitalization	23,295	12,579	16,805	14,062	20,310	29,536
Market Cap Growth	15.82%	-25.15%	19.50%	-30.76%	-31.23%	24.82%
Enterprise Value	22,534	11,783	15,847	12,891	19,519	28,724
Last Close Price	57.29	30.44	39.69	33.27	48.77	70.26
PE Ratio	59.73	35.25	285.02	151.93	30.17	48.76
Forward PE	46.20	60.69	60.69	60.69	60.69	60.69
PS Ratio	10.31	5.89	10.96	9.81	10.18	18.61
PB Ratio	7.04	3.95	5.32	4.53	7.85	13.84
P/TBV Ratio	7.76	4.36	5.89	5.05	8.85	15.03
P/FCF Ratio	111.48	73.20	-	-	46.36	70.55
P/OCF Ratio	56.06	28.44	227.43	109.48	30.17	53.14
EV/Sales Ratio	9.98	5.52	10.34	8.99	9.79	18.10
EV/EBITDA Ratio	45.51	26.37	130.66	110.07	24.96	42.03
EV/EBIT Ratio	60.95	35.24	813.83	417.18	27.21	45.37
EV/FCF Ratio	107.84	68.57	-	-	44.55	68.61
Debt / Equity Ratio	0.12	0.12	0.19	0.02	0.01	-
Debt / EBITDA Ratio	0.79	0.84	4.57	0.55	0.03	-
Debt / FCF Ratio	1.87	2.24	-	-	0.05	-
Asset Turnover	0.50	0.47	0.36	0.39	0.66	0.65
Inventory Turnover	0.60	0.58	0.50	0.42	0.53	0.46
Quick Ratio	1.74	1.59	1.66	2.35	2.34	3.19
Current Ratio	3.21	2.99	2.74	3.80	3.32	4.47
Return on Equity (ROE)	13.18%	12.15%	2.76%	3.85%	29.29%	31.63%
Return on Assets (ROA)	5.09%	4.61%	0.28%	0.53%	14.90%	16.23%
Return on Capital (ROIC)	6.17%	5.70%	0.35%	0.67%	18.91%	20.36%
Return on Capital Employed (ROCE)	10.40%	9.60%	0.60%	1.00%	27.00%	28.80%
Earnings Yield	1.71%	2.84%	0.35%	0.66%	3.31%	2.05%
FCF Yield	0.90%	1.37%	-1.38%	-1.11%	2.16%	1.42%
Dividend Yield	0.81%	1.64%	0.63%	-	1.03%	1.14%
Payout Ratio	29.46%	33.09%	16.00%	226.22%	48.14%	39.85%
Buyback Yield / Dilution	1.18%	1.49%	-0.10%	-4.35%	-0.52%	0.04%
Total Shareholder Return	1.98%	3.13%	0.53%	-4.35%	0.51%	1.18%

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.